Oxford Asset Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-93,589
| Closed | -$62K | – | 2041 |
|
|
2019
Q1 | $62K | Buy |
93,589
+36,534
| +64% | +$24.2K | ﹤0.01% | 1588 |
|
|
2018
Q4 | $98K | Buy |
+57,055
| New | +$98K | ﹤0.01% | 1649 |
|
|
2018
Q1 | – | Sell |
-22,097
| Closed | -$165K | – | 1976 |
|
|
2017
Q4 | $165K | Buy |
+22,097
| New | +$165K | ﹤0.01% | 1479 |
|
|
2017
Q1 | – | Sell |
-24,660
| Closed | -$139K | – | 1514 |
|
|
2016
Q4 | $139K | Buy |
24,660
+7,967
| +48% | +$44.9K | ﹤0.01% | 721 |
|
|
2016
Q3 | $247K | Sell |
16,693
-78,574
| -82% | -$1.16M | 0.01% | 687 |
|
|
2016
Q2 | $855K | Sell |
95,267
-52,552
| -36% | -$472K | 0.03% | 514 |
|
|
2016
Q1 | $1.37M | Buy |
+147,819
| New | +$1.37M | 0.04% | 433 |
|